Metraipolis › archive › dc_89b8bef3ceb5

Circulating tumour cell-derived xenograft as a preclinical platform for metastatic breast cancer — Europe PMC PMID:42151560

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42151560
DOI
10.1038/s41416-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-11-02T05:27:17.683Z
SHA-256 of the archived text
b09e1be3246368dc9cb9d2ad3aa791385cb134896c0f5a089cadea7843d0fe8b
Stable URL of this page
https://metraipolis.com/documento/dc_89b8bef3ceb5

How to cite

Circulating tumour cell-derived xenograft as a preclinical platform for metastatic breast cancer — Europe PMC PMID:42151560 — Europe PMC (en), https://europepmc.org/article/MED/42151560 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_89b8bef3ceb5 (Metraipolis archive dc_89b8bef3ceb5, sha256 b09e1be3246368dc9cb9d2ad3aa791385cb134896c0f5a089cadea7843d0fe8b)
BibTeX
@misc{dc89b8bef3ceb5,
  title = {Circulating tumour cell-derived xenograft as a preclinical platform for metastatic breast cancer — Europe PMC PMID:42151560},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42151560},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_89b8bef3ceb5; sha256 b09e1be3246368dc9cb9d2ad3aa791385cb134896c0f5a089cadea7843d0fe8b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42151560. Agents can read the archived copy with the MCP tool read_document.